CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Clinical implication of the new indication of Empagliflozin Jardiance in the full spectrum of HF

Document ID: PC-PH-104059

06/12/2022

Author: Boehringer Ingelheim

Related content

 
PC-PH-104059
Production date: December 2022